Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival
about
sameAs
Cardiac xenotransplantation: progress and challengesClinical xenotransplantation of organs: why aren't we there yet?Coagulation dysregulation as a barrier to xenotransplantation in the primateHistopathologic insights into the mechanism of anti-non-Gal antibody-mediated pig cardiac xenograft rejectionThe role of genetically engineered pigs in xenotransplantation research.Progress in pig-to-non-human primate transplantation models (1998-2013): a comprehensive review of the literatureHuman CD55 expression blocks hyperacute rejection and restricts complement activation in Gal knockout cardiac xenografts.Xenotransplantation literature update September-October 2004.The utility of right ventricular endomyocardial biopsy for the diagnosis of xenograft rejection after CD46 pig-to-baboon cardiac transplantation.Current status of pig heart xenotransplantation.Which anti-platelet therapies might be beneficial in xenotransplantation?The role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options.The pathobiology of pig-to-primate xenotransplantation: a historical review.Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation.Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function.The potentiating effect of hTFPI in the presence of hCD47 reduces the cytotoxicity of human macrophages.T-cell responses during pig-to-primate xenotransplantation.
P2860
Q27024045-377FEFBE-E71F-4FD4-9108-C58441BBF4A0Q28221527-0D2CDBD9-8F5D-4A3F-82B5-4FF31656C8CEQ33381973-440266D6-3E33-4B64-A66F-7EEFE598B9F4Q34018912-CAA4898B-2FC0-4E66-8316-4060A1187E69Q34044894-410603DE-1AF5-4331-A077-7D55BEAC50DFQ34250530-F769B1F9-C42F-4E4E-BB0D-7003FE656A6AQ35857059-32117444-D0CD-42C4-A607-A9B8CCD24B6AQ35983555-00A292C7-15A2-4983-9237-197F57971FCDQ36183720-B68E1C2B-C017-487A-B7E9-EC7E068F8283Q36386394-DD3C00EC-40EF-415A-83CC-C08A35DDE114Q37069089-379AEBC7-E273-4D8B-BC99-9DEC9EDDE9C3Q38191251-5760C79C-E4A5-4D53-BED2-60BE94B6C6F0Q38712532-A034C35C-35DA-49AC-B8B4-949C00E24E5EQ43239968-B6816374-EA5B-44FC-B009-35DA1773E680Q46427137-AC9AC97C-F8AD-45B1-BB70-D694801990D7Q48298658-CFB3B462-5D8A-4461-B1B8-902F562352E9Q52999495-27164760-0CB8-4044-A7CC-DDE3BD7D1E71
P2860
Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Effective antiplatelet therapy ...... oon cardiac xenograft survival
@ast
Effective antiplatelet therapy ...... oon cardiac xenograft survival
@en
Effective antiplatelet therapy ...... oon cardiac xenograft survival
@nl
type
label
Effective antiplatelet therapy ...... oon cardiac xenograft survival
@ast
Effective antiplatelet therapy ...... oon cardiac xenograft survival
@en
Effective antiplatelet therapy ...... oon cardiac xenograft survival
@nl
prefLabel
Effective antiplatelet therapy ...... oon cardiac xenograft survival
@ast
Effective antiplatelet therapy ...... oon cardiac xenograft survival
@en
Effective antiplatelet therapy ...... oon cardiac xenograft survival
@nl
P2093
P2860
P1433
P1476
Effective antiplatelet therapy ...... oon cardiac xenograft survival
@en
P2093
Christopher G A McGregor
David N Fass
Guerard W Byrne
Henry D Tazelaar
Johannes M Schirmer
John S Logan
P2860
P304
P356
10.1111/J.1399-3089.2004.00159.X
P407
P577
2004-09-01T00:00:00Z